Integra Lifesciences Holdings (IART) Other Gross PP&E Adjustments (2010 - 2026)

Integra Lifesciences Holdings has disclosed Other Gross PP&E Adjustments across 17 years of filings, most recently posting -$218.0 million for Q1 2026.

• Other Gross PP&E Adjustments for Q1 2026 came in at -$218.0 million, changed 0.03% year-over-year; the trailing twelve-month figure through Mar 2026 was -$218.0 million (changed 0.03% YoY), and the FY2025 annual result was $740.4 million, up 13.86% from the prior year.
• Other Gross PP&E Adjustments came in at -$218.0 million for Q1 2026 at Integra Lifesciences Holdings, down from $740.4 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $740.4 million in Q4 2025 to a low of -$218.1 million in Q1 2025.
• The 5-year median for Other Gross PP&E Adjustments is -$177.5 million (2023), against an average of -$1.5 million.
• Across the five-year window, Other Gross PP&E Adjustments plunged 55.26% in 2022 and increased 19.9% in 2024, its largest moves.
• Integra Lifesciences Holdings' Other Gross PP&E Adjustments stood at $482.6 million in 2022, then increased by 12.39% to $542.3 million in 2023, then gained by 19.9% to $650.3 million in 2024, then gained by 13.86% to $740.4 million in 2025, then tumbled by 129.44% to -$218.0 million in 2026.
• The last three Other Gross PP&E Adjustments figures came in at -$218.0 million (Q1 2026), $740.4 million (Q4 2025), and -$165.1 million (Q3 2025), per Business Quant data.